Physician profile
Luis E Marin
NPI 1134116379
$24,472.08
in general payments reported to CMS, 2019-2025
49 companies · $1,873 in 2025
The $1,873 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $749 · 2020: $474 · 2021: $8,513 · 2022: $1,157 · 2023: $965 · 2024: $11K · 2025: $1,873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $9,380 · Food and Beverage: $4,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $9,380.00 |
| Food and Beverage | $4,198.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $9,723.11 | 2022-2024 | Restrata Wound Matrix |
| Dne LLC | $5,923.78 | 2021 | |
| Stryker Corporation | $1,628.37 | 2019-2025 | Salvation, Citrefix, Prostep |
| Southern Edge Orthopaedics, INC. | $1,200.00 | 2021 | |
| Convatec INC. | $974.03 | 2024-2025 | |
| Depuy Synthes Sales INC. | $569.31 | 2019-2025 | Speed, Hammerlock, Dynaforce |
| Horizon Therapeutics Plc | $489.47 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $425.32 | 2021 | |
| Organogenesis INC. | $418.13 | 2021-2025 | Puraply Wound Matrix, Puraply, Apligraf |
| Integra Lifesciences Corporation | $338.70 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $337.95 | 2019-2025 | Collagenase Santyl, Regranex, Pico 14 |
| Polynovo North America LLC | $224.70 | 2025 | Novosorb Btm |
| Innovation Technologies INC | $219.30 | 2021-2023 | Irrisept |
| Biocomposites INC | $154.21 | 2022 | |
| Djo, LLC | $139.31 | 2019-2025 | Cmf |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $135.39 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Access Pro Medical, LLC | $125.00 | 2025 | Matriderm |
| Gramercy Extremity Orthopedics LLC | $121.88 | 2021 | |
| Melinta Therapeutics, LLC | $93.03 | 2019-2020 | |
| Davol INC. | $84.28 | 2024 | Arista Ah Flexitip |
| Bioventus LLC | $80.94 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Embody, INC. | $79.00 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $75.40 | 2022-2023 | Seglentis |
| Ossio INC | $70.52 | 2020 | |
| Paratek Pharmaceuticals, INC. | $68.61 | 2021-2025 | Nuzyra |
| Aroa Biosurgery Incorporated | $65.63 | 2024 | |
| Abbvie INC. | $58.15 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $54.28 | 2019-2023 | Accufill |
| Kci USA, INC. | $50.72 | 2022-2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Ets Wound Care LLC | $49.98 | 2023-2024 | Mirragen Advanced Wound Matrix |
| Grt US Holding, INC. | $49.90 | 2021 | |
| Wright Medical Technology, INC. | $47.17 | 2019-2020 | |
| Treace Medical Concepts, INC. | $45.20 | 2025 | |
| Biotissue Holdings INC. | $43.34 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $36.32 | 2019 | |
| Nabriva Therapeutics, Plc | $33.08 | 2020-2021 | |
| Paragon 28, INC. | $29.29 | 2019 | |
| Stimwave Technologies Incorporated | $26.60 | 2021-2022 | |
| Novo Nordisk INC | $23.96 | 2023 | Ozempic, Rybelsus |
| Reprise Biomedical, INC. | $20.30 | 2023 | Miro3d |
| Ibsa Pharma INC. | $20.00 | 2024 | Licart, Tirosint |
| Hartmann USA, INC. | $18.46 | 2023 | Zetuvit Plus |
| Sanara Medtech INC. | $18.00 | 2025 | Celleraterx |
| Medtronic, INC. | $14.58 | 2023 | Venaseal |
| Amniox Medical, INC. | $14.27 | 2019 | |
| Zyla Life Sciences, INC. | $14.16 | 2019 | |
| Urgo Medical North America, LLC | $14.08 | 2025 | Urgok2 |
| Acell, INC. | $12.80 | 2019 | |
| Iroko Pharmaceuticals, LLC | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Marin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.